Procter & Gamble Company (PG)
Return on equity (ROE)
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 15,974,000 | 15,495,000 | 15,480,000 | 14,318,000 | 14,880,000 | 15,127,000 | 14,770,000 | 15,235,000 | 14,653,000 | 14,321,000 | 14,279,000 | 14,569,000 | 14,742,000 | 14,596,000 | 14,510,000 | 14,141,000 | 14,306,000 | 14,200,000 | 13,848,000 | 13,711,000 |
| Total stockholders’ equity | US$ in thousands | 52,284,000 | 52,272,000 | 51,168,000 | 51,840,000 | 50,286,000 | 50,058,000 | 48,534,000 | 47,692,000 | 46,777,000 | 45,140,000 | 44,455,000 | 44,075,000 | 46,589,000 | 45,478,000 | 44,618,000 | 46,111,000 | 46,378,000 | 46,596,000 | 48,181,000 | 48,182,000 |
| ROE | 30.55% | 29.64% | 30.25% | 27.62% | 29.59% | 30.22% | 30.43% | 31.94% | 31.33% | 31.73% | 32.12% | 33.06% | 31.64% | 32.09% | 32.52% | 30.67% | 30.85% | 30.47% | 28.74% | 28.46% |
June 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $15,974,000K ÷ $52,284,000K
= 30.55%
The Procter & Gamble Company's Return on Equity (ROE) over the period from September 2020 to June 2025 exhibits notable fluctuations, reflecting variations in the company's profitability relative to shareholders' equity. At the beginning of the period, the ROE stood at 28.46% as of September 30, 2020, and demonstrated a gradual upward trend, reaching a high of approximately 33.06% on September 30, 2022. This indicates improved efficiency in generating profit from shareholders' investments during this period.
Subsequently, the ROE experienced a slight decline, decreasing to approximately 32.12% by December 2022. This downward trend persisted into 2023, with the ROE falling marginally to 31.33% in June 2023 and settling at approximately 31.94% by September 2023. Such fluctuations suggest periods of stabilization and minor declines in profitability relative to equity.
In late 2023 and into 2024, the ROE showed further variability, with a notable decline to around 27.62% as of September 2024, the lowest point within the observed period. This decrease could reflect temporary challenges in profitability or changes in the company's financial structure. However, in the subsequent quarters, the ROE recovered slightly, reaching approximately 30.25% in December 2024, before dipping again to around 29.64% in March 2025 and slightly rebounding to 30.55% by June 2025.
Overall, the ROE trajectory indicates that Procter & Gamble has maintained a relatively high level of shareholder return on equity throughout the examined period, generally ranging between approximately 28% and 33%. Despite some fluctuations, the company has demonstrated resilience and consistent profitability. The recent downward trends toward the end of the period may warrant further analysis of underlying factors such as changes in net income, equity base, or external market conditions influencing these ratios.
See also:
Procter & Gamble Company Return on Equity (ROE) (Quarterly Data)